Awarded
PURCON924 - PUFA IMP and Placebo
Descriptions
We are looking to contract with a manufacturer who can:, • Provide active Omacor capsules of n-3 PUFA (eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in 1g capsules in a 1.3:1 ratio in accordance with specified regulations;, • Manufac ....see more
Timeline
Published Date :
26th Apr 2021
in 5 days
Deadline :
8th Jun 2026
in 25 days
Contract Start :
N/A
Contract End :
N/A
Tender Regions
CPV Codes
Workflows
Status :
Awarded
Details
Buyer Information
Name :
Procurement Contact
Name :
Tina Smith
Phone :
0151 252 3243
Email :
tina.smith@shared-ed.ac.uk